New pill for advanced cancers enters early human testing
NCT ID NCT06143007
First seen Nov 17, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This early-phase study tests an experimental tablet called BB3008 in about 42 adults with advanced solid tumors who have run out of standard treatments. The main goals are to check the drug's safety, find the best dose, and see how food affects it. Participants take the pill by mouth and are closely monitored for side effects and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100005, China
Conditions
Explore the condition pages connected to this study.